Martin M. Dokter

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

IL-17 is associated with disease severity and targetable inflammatory processes in heart failure.

IL-17 is associated with disease severity and targetable inflammatory processes in heart failure.

Journal: ESC heart failure

Published: June 20, 2024

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling.

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling.

Journal: Scientific reports

Published: October 27, 2022

Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease.

Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease.

Journal: Cardiovascular diabetology

Published: October 06, 2022

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.

Journal: Circulation. Heart failure

Published: September 30, 2021

Pectins from various sources inhibit galectin-3-related cardiac fibrosis.

Pectins from various sources inhibit galectin-3-related cardiac fibrosis.

Journal: Current research in translational medicine

Published: January 25, 2021

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: November 03, 2020

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

Journal: Cardiovascular drugs and therapy

Published: July 03, 2020

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.

Journal: Cardiovascular drugs and therapy

Published: May 28, 2020

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.

Journal: Cardiovascular research

Published: April 03, 2020

Tumour biomarkers: association with heart failure outcomes.

Tumour biomarkers: association with heart failure outcomes.

Journal: Journal of internal medicine

Published: January 16, 2020

Selenium and outcome in heart failure.

Selenium and outcome in heart failure.

Journal: European journal of heart failure

Published: April 23, 2019

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 12, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026